Healthy Investment

– The value of sector annual production is Eur 308 mill.
– Generic drugs development strategy
– Cost efficiency & intellectual capacities
– Market potentials & commitment to quality

Serbia Business produced several briefs on market status covering producers, distributors and local outsourced partners. Pharma sector in Serbia is one of the most perspective business areas.